[
    "{\"step_by_step_thinking\": \"The patient presents with a racing heart and lightheadedness, and the ECG shows the absence of P-waves with an irregular RR complex. These findings are consistent with atrial fibrillation. The patient has a history of myocardial infarction and is currently taking anticoagulation therapy. Therefore, the most likely mechanism of action for the new medication is to activate the antithrombin enzyme, which is the mechanism of action for heparin, an anticoagulant commonly used in the treatment of atrial fibrillation.\", \"answer_choice\": \"A\"}"
]